EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Werte in diesem Artikel
|
EQS Preliminary announcement financial reports: Dermapharm Holding SE
/ Preliminary announcement on the disclosure of financial statements
Werbung Werbung
Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report of the group Language: German Date of disclosure: March 31, 2026 Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/ Language: English Date of disclosure: March 31, 2026 Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/
20.03.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Dermapharm Holding SE |
| Lil-Dagover-Ring 7 | |
| 82031 Grünwald | |
| Germany | |
| Internet: | ir.dermapharm.de |
| End of News | EQS News Service |
|
|
2295226 20.03.2026 CET/CEST
Ausgewählte Hebelprodukte auf Dermapharm
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Dermapharm
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|